questionsmedicales.fr
Phénomènes physiologiques respiratoires et circulatoires
Phénomènes physiologiques respiratoires
Capacité pulmonaire totale
Capacité vitale
Capacité vitale : Questions médicales fréquentes
Termes MeSH sélectionnés :
Diagnostic
5
Spirométrie
Fonction pulmonaire
Pléthysmographie
Gaz du sang
Capacité vitale
Normes physiologiques
Dyspnée
Maladies pulmonaires
Symptômes
5
Essoufflement
Oppression thoracique
Douleurs thoraciques
Cyanose
Âge
Dégradation pulmonaire
Prévention
5
Tabagisme
Activité physique
Vaccins
Infections respiratoires
Exercice physique
Fonction pulmonaire
Hydratation
Voies respiratoires
Traitements
5
Réhabilitation pulmonaire
Bronchodilatateurs
Physiothérapie
Fonction pulmonaire
Médicaments
Bronchodilatateurs
Complications
5
Insuffisance respiratoire
Infections pulmonaires
Capacité vitale
Complications respiratoires
Maladies cardiaques
Capacité vitale
Infections pulmonaires
Inflammation
Effets à long terme
Santé respiratoire
Facteurs de risque
5
Âge
Dégradation pulmonaire
Environnement de travail
Pollution
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Capacité vitale : Questions médicales les plus fréquentes",
"headline": "Capacité vitale : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Capacité vitale : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-01-22",
"dateModified": "2025-04-16",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Capacité vitale"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Capacité pulmonaire totale",
"url": "https://questionsmedicales.fr/mesh/D014109",
"about": {
"@type": "MedicalCondition",
"name": "Capacité pulmonaire totale",
"code": {
"@type": "MedicalCode",
"code": "D014109",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "G09.772.850"
}
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Volume de réserve expiratoire",
"alternateName": "Expiratory Reserve Volume",
"url": "https://questionsmedicales.fr/mesh/D005105",
"about": {
"@type": "MedicalCondition",
"name": "Volume de réserve expiratoire",
"code": {
"@type": "MedicalCode",
"code": "D005105",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "G09.772.850.970.360"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Capacité inspiratoire",
"alternateName": "Inspiratory Capacity",
"url": "https://questionsmedicales.fr/mesh/D007320",
"about": {
"@type": "MedicalCondition",
"name": "Capacité inspiratoire",
"code": {
"@type": "MedicalCode",
"code": "D007320",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "G09.772.850.970.500"
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Volume de réserve inspiratoire",
"alternateName": "Inspiratory Reserve Volume",
"url": "https://questionsmedicales.fr/mesh/D007321",
"about": {
"@type": "MedicalCondition",
"name": "Volume de réserve inspiratoire",
"code": {
"@type": "MedicalCode",
"code": "D007321",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "G09.772.850.970.500.375"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Volume courant",
"alternateName": "Tidal Volume",
"url": "https://questionsmedicales.fr/mesh/D013990",
"about": {
"@type": "MedicalCondition",
"name": "Volume courant",
"code": {
"@type": "MedicalCode",
"code": "D013990",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "G09.772.850.970.500.700"
}
}
}
]
}
],
"about": {
"@type": "MedicalCondition",
"name": "Capacité vitale",
"alternateName": "Vital Capacity",
"code": {
"@type": "MedicalCode",
"code": "D014797",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "None None",
"url": "https://questionsmedicales.fr/author/None%20None",
"affiliation": {
"@type": "Organization",
"name": ""
}
},
{
"@type": "Person",
"name": "Toby M Maher",
"url": "https://questionsmedicales.fr/author/Toby%20M%20Maher",
"affiliation": {
"@type": "Organization",
"name": "Keck School of Medicine, University of Southern California, Los Angeles, California, USA."
}
},
{
"@type": "Person",
"name": "Hyun Lee",
"url": "https://questionsmedicales.fr/author/Hyun%20Lee",
"affiliation": {
"@type": "Organization",
"name": "Division of Pulmonary Medicine and Allergy, Department of Internal Medicine, Hanyang University College of Medicine, Seoul, South Korea."
}
},
{
"@type": "Person",
"name": "Hye Yun Park",
"url": "https://questionsmedicales.fr/author/Hye%20Yun%20Park",
"affiliation": {
"@type": "Organization",
"name": "Division of Pulmonary and Critical Care Medicine, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea."
}
},
{
"@type": "Person",
"name": "Masato Kono",
"url": "https://questionsmedicales.fr/author/Masato%20Kono",
"affiliation": {
"@type": "Organization",
"name": "Department of Respiratory Medicine, Seirei Hamamatsu General Hospital, Hamamatsu, Japan. Electronic address: masato.k@sis.seirei.or.jp."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "Photoswitchable Probes of Oxytocin and Vasopressin.",
"datePublished": "2023-10-19",
"url": "https://questionsmedicales.fr/article/37857356",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1021/acs.jmedchem.3c01415"
}
},
{
"@type": "ScholarlyArticle",
"name": "Modulation of social behavior by distinct vasopressin sources.",
"datePublished": "2023-02-13",
"url": "https://questionsmedicales.fr/article/36860367",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.3389/fendo.2023.1127792"
}
},
{
"@type": "ScholarlyArticle",
"name": "Vasopressin Response and Clinical Trajectory in Septic Shock Patients.",
"datePublished": "2022-09-04",
"url": "https://questionsmedicales.fr/article/36062611",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1177/08850666221118282"
}
},
{
"@type": "ScholarlyArticle",
"name": "Norepinephrine and Vasopressin in Hemorrhagic Shock: A Focus on Renal Hemodynamics.",
"datePublished": "2023-02-17",
"url": "https://questionsmedicales.fr/article/36835514",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.3390/ijms24044103"
}
},
{
"@type": "ScholarlyArticle",
"name": "Meta-Analysis of Efficacy of Vasopressin During Cardiopulmonary Resuscitation.",
"datePublished": "2022-08-05",
"url": "https://questionsmedicales.fr/article/35934565",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.amjcard.2022.06.042"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Phénomènes physiologiques respiratoires et circulatoires",
"item": "https://questionsmedicales.fr/mesh/D002943"
},
{
"@type": "ListItem",
"position": 3,
"name": "Phénomènes physiologiques respiratoires",
"item": "https://questionsmedicales.fr/mesh/D012143"
},
{
"@type": "ListItem",
"position": 4,
"name": "Capacité pulmonaire totale",
"item": "https://questionsmedicales.fr/mesh/D014109"
},
{
"@type": "ListItem",
"position": 5,
"name": "Capacité vitale",
"item": "https://questionsmedicales.fr/mesh/D014797"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Capacité vitale - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Capacité vitale",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-16",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Capacité vitale",
"description": "Comment évaluer la capacité vitale ?\nQuels tests complètent l'évaluation ?\nQuels sont les critères normaux de capacité vitale ?\nQuand suspecter une capacité vitale réduite ?\nQuels signes indiquent un problème pulmonaire ?",
"url": "https://questionsmedicales.fr/mesh/D014797?mesh_terms=Vasopressins#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Capacité vitale",
"description": "Quels symptômes sont liés à une capacité vitale faible ?\nLa toux est-elle un symptôme associé ?\nComment la fatigue se manifeste-t-elle ?\nY a-t-il des signes d'alerte ?\nLes symptômes varient-ils selon l'âge ?",
"url": "https://questionsmedicales.fr/mesh/D014797?mesh_terms=Vasopressins#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Capacité vitale",
"description": "Comment prévenir la réduction de la capacité vitale ?\nLes vaccinations sont-elles importantes ?\nQuel rôle joue l'exercice physique ?\nFaut-il éviter certaines expositions ?\nL'hydratation est-elle importante ?",
"url": "https://questionsmedicales.fr/mesh/D014797?mesh_terms=Vasopressins#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Capacité vitale",
"description": "Quels traitements améliorent la capacité vitale ?\nLa physiothérapie est-elle utile ?\nLes médicaments peuvent-ils aider ?\nQuand envisager une intervention chirurgicale ?\nLes traitements varient-ils selon la cause ?",
"url": "https://questionsmedicales.fr/mesh/D014797?mesh_terms=Vasopressins#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Capacité vitale",
"description": "Quelles complications peuvent survenir ?\nLa capacité vitale faible augmente-t-elle les risques ?\nLes maladies cardiaques sont-elles liées ?\nComment les infections affectent-elles la capacité vitale ?\nY a-t-il des effets à long terme ?",
"url": "https://questionsmedicales.fr/mesh/D014797?mesh_terms=Vasopressins#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Capacité vitale",
"description": "Quels sont les principaux facteurs de risque ?\nL'âge influence-t-il la capacité vitale ?\nLes maladies chroniques sont-elles un facteur ?\nLe sexe joue-t-il un rôle ?\nL'environnement de travail est-il un facteur ?",
"url": "https://questionsmedicales.fr/mesh/D014797?mesh_terms=Vasopressins#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment évaluer la capacité vitale ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "La capacité vitale est mesurée par spirométrie, un test de la fonction pulmonaire."
}
},
{
"@type": "Question",
"name": "Quels tests complètent l'évaluation ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des tests comme la pléthysmographie et les gaz du sang peuvent être utilisés."
}
},
{
"@type": "Question",
"name": "Quels sont les critères normaux de capacité vitale ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les valeurs normales varient selon l'âge, le sexe et la taille, généralement entre 3 et 6 L."
}
},
{
"@type": "Question",
"name": "Quand suspecter une capacité vitale réduite ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une capacité vitale réduite est suspectée en cas de dyspnée ou d'antécédents de maladies pulmonaires."
}
},
{
"@type": "Question",
"name": "Quels signes indiquent un problème pulmonaire ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des signes comme la toux persistante ou la fatigue peuvent indiquer une capacité vitale altérée."
}
},
{
"@type": "Question",
"name": "Quels symptômes sont liés à une capacité vitale faible ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes incluent essoufflement, fatigue, et sensation d'oppression thoracique."
}
},
{
"@type": "Question",
"name": "La toux est-elle un symptôme associé ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, une toux persistante peut accompagner une capacité vitale diminuée."
}
},
{
"@type": "Question",
"name": "Comment la fatigue se manifeste-t-elle ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "La fatigue peut se manifester par une diminution de l'énergie et des difficultés à l'effort."
}
},
{
"@type": "Question",
"name": "Y a-t-il des signes d'alerte ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des signes comme des douleurs thoraciques ou une cyanose nécessitent une attention médicale immédiate."
}
},
{
"@type": "Question",
"name": "Les symptômes varient-ils selon l'âge ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les symptômes peuvent être plus prononcés chez les personnes âgées en raison de la dégradation pulmonaire."
}
},
{
"@type": "Question",
"name": "Comment prévenir la réduction de la capacité vitale ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "Éviter le tabagisme, pratiquer une activité physique régulière et avoir une alimentation équilibrée."
}
},
{
"@type": "Question",
"name": "Les vaccinations sont-elles importantes ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les vaccins contre la grippe et le pneumocoque aident à prévenir les infections respiratoires."
}
},
{
"@type": "Question",
"name": "Quel rôle joue l'exercice physique ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'exercice régulier améliore la fonction pulmonaire et la capacité vitale."
}
},
{
"@type": "Question",
"name": "Faut-il éviter certaines expositions ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, éviter les polluants et les allergènes peut aider à préserver la santé pulmonaire."
}
},
{
"@type": "Question",
"name": "L'hydratation est-elle importante ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, une bonne hydratation aide à maintenir la santé des voies respiratoires."
}
},
{
"@type": "Question",
"name": "Quels traitements améliorent la capacité vitale ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les traitements incluent la réhabilitation pulmonaire, les bronchodilatateurs et les corticostéroïdes."
}
},
{
"@type": "Question",
"name": "La physiothérapie est-elle utile ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, la physiothérapie respiratoire aide à améliorer la capacité vitale et la fonction pulmonaire."
}
},
{
"@type": "Question",
"name": "Les médicaments peuvent-ils aider ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des médicaments comme les bronchodilatateurs peuvent aider à ouvrir les voies respiratoires."
}
},
{
"@type": "Question",
"name": "Quand envisager une intervention chirurgicale ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une chirurgie peut être envisagée en cas de maladies pulmonaires graves, comme la BPCO."
}
},
{
"@type": "Question",
"name": "Les traitements varient-ils selon la cause ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le traitement dépend de la cause sous-jacente de la réduction de la capacité vitale."
}
},
{
"@type": "Question",
"name": "Quelles complications peuvent survenir ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des complications incluent l'insuffisance respiratoire et des infections pulmonaires."
}
},
{
"@type": "Question",
"name": "La capacité vitale faible augmente-t-elle les risques ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, une capacité vitale faible augmente le risque de complications respiratoires graves."
}
},
{
"@type": "Question",
"name": "Les maladies cardiaques sont-elles liées ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, une capacité vitale réduite peut être associée à un risque accru de maladies cardiaques."
}
},
{
"@type": "Question",
"name": "Comment les infections affectent-elles la capacité vitale ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les infections pulmonaires peuvent réduire la capacité vitale en provoquant une inflammation."
}
},
{
"@type": "Question",
"name": "Y a-t-il des effets à long terme ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, une capacité vitale réduite peut entraîner des effets à long terme sur la santé respiratoire."
}
},
{
"@type": "Question",
"name": "Quels sont les principaux facteurs de risque ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les principaux facteurs incluent le tabagisme, l'exposition à des polluants et des antécédents familiaux."
}
},
{
"@type": "Question",
"name": "L'âge influence-t-il la capacité vitale ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, la capacité vitale diminue généralement avec l'âge en raison de la dégradation pulmonaire."
}
},
{
"@type": "Question",
"name": "Les maladies chroniques sont-elles un facteur ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des maladies comme l'asthme ou la BPCO augmentent le risque de capacité vitale réduite."
}
},
{
"@type": "Question",
"name": "Le sexe joue-t-il un rôle ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les hommes ont généralement une capacité vitale plus élevée que les femmes en moyenne."
}
},
{
"@type": "Question",
"name": "L'environnement de travail est-il un facteur ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, travailler dans des environnements pollués ou dangereux peut affecter la capacité vitale."
}
}
]
}
]
}
Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale
Validation scientifique effectuée le 16/04/2025
Contenu vérifié selon les dernières recommandations médicales
5 publications dans cette catégorie
Publications dans "Capacité vitale" :
3 publications dans cette catégorie
Affiliations :
Keck School of Medicine, University of Southern California, Los Angeles, California, USA.
Imperial College London, London, UK.
Publications dans "Capacité vitale" :
3 publications dans cette catégorie
Affiliations :
Division of Pulmonary Medicine and Allergy, Department of Internal Medicine, Hanyang University College of Medicine, Seoul, South Korea.
Publications dans "Capacité vitale" :
3 publications dans cette catégorie
Affiliations :
Division of Pulmonary and Critical Care Medicine, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea.
Publications dans "Capacité vitale" :
3 publications dans cette catégorie
Affiliations :
Department of Respiratory Medicine, Seirei Hamamatsu General Hospital, Hamamatsu, Japan. Electronic address: masato.k@sis.seirei.or.jp.
Publications dans "Capacité vitale" :
3 publications dans cette catégorie
Affiliations :
Second Division, Department of Internal Medicine, Hamamatsu University School of Medicine, Hamamatsu, Japan.
Publications dans "Capacité vitale" :
3 publications dans cette catégorie
Affiliations :
Department of Respiratory Medicine, Seirei Hamamatsu General Hospital, Hamamatsu, Japan.
Publications dans "Capacité vitale" :
2 publications dans cette catégorie
Affiliations :
University of California San Francisco, 8785, San Francisco, California, United States.
Publications dans "Capacité vitale" :
2 publications dans cette catégorie
Affiliations :
Gerontology Department and Frailty in Ageing Research Department, Vrije Universiteit Brussel, Brussels, Belgium; Department of Geriatrics, Universitair Ziekenhuis Brussel, Brussels, Belgium. Electronic address: ivan.bautmans@vub.be.
Publications dans "Capacité vitale" :
2 publications dans cette catégorie
Affiliations :
Gerontology Department and Frailty in Ageing Research Department, Vrije Universiteit Brussel, Brussels, Belgium.
Publications dans "Capacité vitale" :
2 publications dans cette catégorie
Affiliations :
Ageing and Health Unit, WHO, Geneva, Switzerland.
Publications dans "Capacité vitale" :
2 publications dans cette catégorie
Affiliations :
Department of Human Movement Sciences, @AgeAmsterdam, Amsterdam Movement Sciences, Vrije Universiteit Amsterdam, Amsterdam, Netherlands; Department of Medicine and Aged Care, @AgeMelbourne, The University of Melbourne, The Royal Melbourne Hospital, Parkville, VIC, Australia; Yong Loo Lin School of Medicine, Centre for Healthy Longevity, National University of Singapore, Singapore; National University Health System, Singapore.
Publications dans "Capacité vitale" :
2 publications dans cette catégorie
Affiliations :
Institute for Biomedicine of Aging, University of Erlangen-Nuremberg, Nuremberg, Germany.
Publications dans "Capacité vitale" :
2 publications dans cette catégorie
Affiliations :
Centre de Recherche de l'Institut Universitaire de Gériatrie de Montréal, Montreal, QC, Canada; Faculty of Sciences, Department of Exercise Sciences, Université du Québec à Montréal, QC, Canada.
Publications dans "Capacité vitale" :
2 publications dans cette catégorie
Affiliations :
Department of Medicine, Firestone Institute for Respiratory Health, McMaster University, Hamilton, ON, Canada.
Publications dans "Capacité vitale" :
2 publications dans cette catégorie
Affiliations :
Boehringer Ingelheim International GmbH, Ingelheim am Rhein, Germany.
Publications dans "Capacité vitale" :
2 publications dans cette catégorie
Affiliations :
Center for Interstitial and Rare Lung Diseases, Pneumology and Respiratory Care Medicine, Thoraxklinik, University of Heidelberg, Member of the German Center for Lung Research, Heidelberg, Germany.
Publications dans "Capacité vitale" :
2 publications dans cette catégorie
Affiliations :
Weill Cornell Medicine, New York, New York, USA.
Publications dans "Capacité vitale" :
2 publications dans cette catégorie
Affiliations :
Department of Medicine, University of North Carolina, Chapel Hill, NC, USA.
Publications dans "Capacité vitale" :
2 publications dans cette catégorie
Affiliations :
Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, Konkuk University Medical Center, Konkuk University School of Medicine, Seoul, South Korea.
Publications dans "Capacité vitale" :
Oxytocin (OT) and vasopressin (VP) are related neuropeptides that regulate many biological processes. In humans, OT and VP act via four G protein-coupled receptors, OTR, V...
The neuropeptide arginine-vasopressin (AVP) is well known for its peripheral effects on blood pressure and antidiuresis. However, AVP also modulates various social and anxiety-related behaviors by its...
In septic shock, vasopressors aim to improve tissue perfusion and prevent persistent organ dysfunction, a characteristic of chronic critical illness (CCI). Adjunctive vasopressin is often used to decr...
We included patients with septic shock receiving vasopressin as a catecholamine adjunct in this retrospective cohort study. We defined vasopressin response as a lowering of the catecholamine dose requ...
In total 938 patients were included; 426 (45.4%) were vasopressin responders. The most frequent trajectory was ED (49.8%), 29.7% developed CCI, and 20.5% had rapid recovery. In survivors to ICU day 14...
Vasopressin responsive status was associated with improved clinical trajectory in septic shock patients. Early vasopressin response is a potential novel prognostic marker for short-term clinical traje...
During hemorrhagic shock, blood loss causes a fall in blood pressure, decreases cardiac output, and, consequently, O...
Randomized controlled trials evaluating the efficacy of vasopressin versus standard of care during cardiopulmonary resuscitation (CPR) have yielded conflicting results. An electronic search of MEDLINE...
The diabetic kidney disease (DKD) is the major cause of the chronic kidney disease (CKD). Enhanced plasma vasopressin (VP) levels have been associated with the pathophysiology of DKD and CKD. Stimulat...
Vasopressin is increasingly used in infants following cardiac surgery. Hyponatremia is a noted adverse event, but incidence and risk factors remain undefined....
The primary objective was to identify the incidence of vasopressin-induced hyponatremia. Secondary objectives included comparing baseline and change in serum sodium concentrations between infants rece...
This Institutional Review Board-approved, retrospective case-control study included infants <6 months following cardiac surgery receiving vasopressin for ≥6 hours at a tertiary care, academic hospital...
Of the included 142 infants, 20 (14.1%) developed hyponatremia and were matched with 40 controls. There was significant difference in median nadir between controls and cases, 142.0 versus 128.5 mEq/L ...
Vasopressin-induced hyponatremia incidence was <15%. Vasopressin duration was independently associated with hyponatremia development....
To describe the acute hemodynamic effect of vasopressin on the Fontan circulation, including systemic and pulmonary pressures and resistances, left atrial pressure, and cardiac index....
Prospective, open-label, nonrandomized study (NCT04463394)....
Cardiac catheterization laboratory at Lucile Packard Children's Hospital, Stanford....
Patients 3-50 years old with a Fontan circulation who were referred to the cardiac catheterization laboratory for hemodynamic assessment and/or intervention....
A 0.03 U/kg IV (maximum dose 1 unit) bolus of vasopressin was administered over 5 minutes, followed by a maintenance infusion of 0.3 mU/kg/min (maximum dose 0.03 U/min)....
Comprehensive cardiac catheterization measurements before and after vasopressin administration. Measurements included pulmonary artery, atrial, and systemic arterial pressures, oxygen saturations, and...
In Fontan patients undergoing cardiac catheterization, vasopressin administration resulted in a significant increase in systolic blood pressure, SVR, and left atrial pressure, decrease in PVR, and no ...
Vasoplegia, or vasoplegic shock, is a syndrome whose main characteristic is reducing blood pressure in the presence of a standard or high cardiac output. For the treatment, vasopressors are recommende...
This is a systematic review of the literature with meta-analysis, written according to the recommendations of the PRISMA report. The SCOPUS, PubMed, and ScienceDirect databases were used to select the...
In total, 2,090 articles were retrieved; after applying the inclusion and exclusion criteria, ten studies were selected to compose the present review. We found no significant difference when assessing...
Considering the outcomes included in our study, it is worth noting that most studies showed that using vasopressin was safe and can be considered in managing postoperative vasoplegic shock....
The use of arginine vasopressin (AVP) and terlipressin to treat hypotension in preterm neonates is increasing. Our aim was to review the available evidence on the efficacy and safety of AVP and terlip...
MEDLINE, EMBASE, the Cochrane Central Register of Controlled Trials, Web of Science, and Google Scholar from inception to September 2021 were searched for studies of AVP and terlipressin in the treatm...
Fifteen studies describing the use of AVP (n = 12) or terlipressin (n = 3) among 148 preterm neonates were included. Certainly, the available evidence for the primary outcome of end-organ perfusion ra...
AVP and terlipressin may improve measured blood pressure values and possibly end-organ perfusion among neonates with refractory hypotension. However, the efficacy-safety balance of these drugs should ...